Clinicopathologic characteristics and clinical outcomes according to the genotype-specific and therapeutic regimens were analyzed, aiming to elucidate the clinical significance of ALK rearrangement in selected advanced NSCLC patients. The gene discussed is ALK; the disease is non-small cell lung carcinoma.